Small Molecules for Immunology, Oncology & COVID

Small Molecules for Immunology and Oncology is a merging of our long-standing Inflammation Inhibitors meeting with our more recent Small Molecules .. Read more for Cancer Immunotherapy conference in recognition of the commonalities among the drug targets in both fields from the standpoint of a medicinal chemist. Evidence is mounting that autoimmunity/inflammation versus cancer can be considered two sides of the same coin. Inflammation arises when the immune system is overactive whereas cancer is largely a result of an underactive or subverted immune system.